Clinical Trials Browser

Phase 2 × plozalizumab × Tumor-Agnostic × Clear all

NCT01015560 2018-08-09

S0916, MLN1202 in Treating Patients With Bone Metastases

Phase 2 Completed

44 enrolled 7 charts

Neoplasm Metastasis